You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Nontuberculous Mycobacterial Lung Disease

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Soluble Programmed Death-1 in Predicting Progression of

Recruiting
  • Nontuberculous Mycobacterial Lung Disease
    • Taipei, Taiwan
      National Taiwan University Hospital
    Jan 18, 2023

    Nontuberculous Mycobacterial Lung Disease Trial in Shanghai (New regimen(BdqCfzLzd+XY))

    Not yet recruiting
    • Nontuberculous Mycobacterial Lung Disease
    • New regimen(BdqCfzLzd+XY)
    • Shanghai, China
      Shanghai Pulmonary Hospital
    Aug 8, 2022

    Mycobacterium Infections, Nontuberculous Trial in Saint Louis (Recombinant human interleukin-7)

    Recruiting
    • Mycobacterium Infections, Nontuberculous
    • Recombinant human interleukin-7
    • Saint Louis, Missouri
      Washington University
    Mar 30, 2022

    Mycobacterial Lung Diseases in Virginia: Sequencing and Clinical

    Recruiting
    • Nontuberculous Mycobacterial Lung Disease
      • Charlottesville, Virginia
        University of Virginia, Division of Infectious Disease
      May 16, 2022

      Nontuberculous Mycobacterial Lung Disease, Nontuberculous Mycobacterium Infection Trial in New York, Portland, Toronto

      Recruiting
      • Nontuberculous Mycobacterial Lung Disease
      • Nontuberculous Mycobacterium Infection
      • Hypertonic saline
      • +3 more
      • New York, New York
      • +2 more
      Jan 27, 2023

      Mycobacterium Infections, Nontuberculous, Mycobacterium Abscessus Infection, Nontuberculous Mycobacterial Lung Disease Trial in

      Recruiting
      • Mycobacterium Infections, Nontuberculous
      • +3 more
      • Omadacycline Oral Tablet
      • Placebo
      • Birmingham, Alabama
      • +20 more
      Jan 11, 2023

      Study of Nontuberculous Mycobacterial Lung Disease

      Recruiting
      • Nontuberculous Mycobacterial Lung Disease
        • Seoul, Korea, Republic of
          Samsung Medical Center
        Nov 23, 2020

        Mycobacterium Abscessus Infection in Chronic Lung Disease and

        Enrolling by invitation
        • Mycobacterium Abscessus Infection
        • +2 more
        • Appropriate treatment
        • Pathum Wan, Bangkok, Thailand
          King Chulalongkorn Memorial Hospital
        Aug 31, 2022

        Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) Trial (Placebo, SPR720 500 mg, SPR720 1000 mg)

        Not yet recruiting
        • Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD)
        • Placebo
        • +2 more
        • (no location specified)
        Aug 9, 2022

        Mycobacterium Avium Complex Pulmonary Disease Trial (Minocycline)

        Not yet recruiting
        • Mycobacterium Avium Complex Pulmonary Disease
        • (no location specified)
        May 15, 2023

        Nontuberculous Mycobacterial Diseases Trial in Nijmegen (Clofazimine)

        Recruiting
        • Nontuberculous Mycobacterial Diseases
        • Nijmegen, Gelderland, Netherlands
          Radboud university medical center
        Sep 9, 2022

        PK and PD of Antibiotics for Treatment of Mycobacterium

        Not yet recruiting
        • Nontuberculous Mycobacterial Pulmonary Infection
        • Measuring PK and PD indices in patients who receive conventional treatment
        • (no location specified)
        Dec 22, 2022

        Patients With Nontuberculous Mycobacterial Lung Disease

        Completed
        • Mycobacterium Infections, Nontuberculous
          • Seoul, Korea, Republic of
            Seoul National University Hospital
          Dec 12, 2019

          Drug Exposure and Minimum Inhibitory Concentration in Treatment

          Not yet recruiting
          • Mycobacterium Avium Complex
          • +3 more
          • Drug exposure
          • Shanghai, China
            Shanghai Pulmonary Hospital
          Apr 10, 2023

          Mycobacterium Infections, Nontuberculous Trial in Worldwide (ALIS, Azithromycin, Ethambutol)

          Active, not recruiting
          • Mycobacterium Infections, Nontuberculous
          • Birmingham, Alabama
          • +110 more
          Jan 23, 2023

          NUTRITIONAL ASSESSMENT IN NON-TUBERCULOUS MYCOBACTERIA PULMONARY

          Recruiting
          • Non-Tuberculous Mycobacterial Pneumonia
            • Monza, MB, Italy
              San Gerardo Hospital
            Oct 21, 2022

            A Registry for Nontuberculous Mycobacterial Pulmonary Disease

            Enrolling by invitation
            • Nontuberculous Mycobacterial Pulmonary Disease
              • Seoul, Korea, Republic of
                Department of Internal Medicine, Yonsei University College of Me
              Nov 15, 2019

              MAC Lung Disease Trial in United States (Epetraborole, Placebo)

              Recruiting
              • MAC Lung Disease
              • Treatment Refractory MAC Lung Disease
              • Birmingham, Alabama
              • +40 more
              Jan 31, 2023

              Factors Related to Non-tuberculous Mycobacterial Pulmonary

              Unknown status
              • Non-Tuberculous Mycobacterial Pneumonia
                • Hong Kong, Please Select, Hong Kong
                  Chinese University of Hong
                Dec 8, 2020

                Mycobacterium Avium Complex, Nontuberculous Mycobacterium Infection Trial in Canada, United States (Azithromycin, Ethambutol,

                Recruiting
                • Mycobacterium Avium Complex
                • Nontuberculous Mycobacterium Infection
                • Loma Linda, California
                • +26 more
                Jan 18, 2023

                Mycobacterium Avium Complex Trial in Baltimore (Azithromycin)

                Recruiting
                • Mycobacterium Avium Complex
                • Baltimore, Maryland
                  Johns Hopkins University School of Medicine
                Mar 7, 2022

                Mycobacterium Infections, Nontuberculous Trial in Canada, United States (Liposomal amikacin for inhalation (LAI), )

                Completed
                Has Results
                • Mycobacterium Infections, Nontuberculous
                • Liposomal amikacin for inhalation (LAI)
                • placebo
                • Birmingham, Alabama
                • +18 more
                Aug 6, 2019

                Non-Tuberculous Mycobacterial Pneumonia, Cystic Fibrosis, Mycobacterial Pneumonia Trial in Greenslopes (LungFit)

                Recruiting
                • Non-Tuberculous Mycobacterial Pneumonia
                • +4 more
                • LungFit
                • Greenslopes, Queensland, Australia
                  Gallipoli Medical Research Foundation
                Dec 24, 2020

                Mycobacterium Infections, Nontuberculous Trial (LAI (Liposomal Amikacin for Inhalation) 590 mg)

                Completed
                Has Results
                • Mycobacterium Infections, Nontuberculous
                • LAI (Liposomal Amikacin for Inhalation) 590 mg
                • (no location specified)
                Apr 22, 2020

                Severe Combined Immunodeficiency (SCID), Immunodeficiency With Predominant T-cell Defect, Unspecified, Severe Chronic

                Enrolling by invitation
                • Severe Combined Immunodeficiency (SCID)
                • +8 more
                • CD3/CD19 negative allogeneic hematopoietic stem cells
                • Pittsburgh, Pennsylvania
                  Children's Hospital of Pittsburgh of UPMC
                Dec 6, 2021